$0.869200
0.044.85%
Pre-Market: Jul 19, 6:07 PM EDT
15 minutes delayed
Comments
Loading...
TransCode Therapeutics
RNAZNASDAQ
TransCode Therapeutics (NASDAQ:RNAZ) Stock, Short Interest Report
Short interest in TransCode Therapeutics Inc (NASDAQ:RNAZ) decreased during the last reporting period, falling from 448.48K to 167.18K. This put 2.3% of the company's publicly available shares short.
Short interest for TransCode Therapeutics gives investors a sense of the degree to which investors are betting on the decline of TransCode Therapeutics's stock. Short interest data is updated every two weeks.
Based on the recent average volume of 204.30K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.
Short Interest
167.18K
Short Interest %
2.30%
Days to Cover
1
| Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| RNAZ | TransCode Therapeutics, Inc. C | 06/28/2024 | 07/10/2024 | 2.30% | 7,259,583 | 167,182 | 204,296 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 06/14/2024 | 06/26/2024 | 6.18% | 7,259,583 | 448,481 | 548,613 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 05/31/2024 | 06/11/2024 | 15.37% | 6,615,978 | 1,016,717 | 1,543,338 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 05/15/2024 | 05/24/2024 | 2.63% | 6,615,978 | 173,933 | 4,193,007 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 04/30/2024 | 05/09/2024 | 2.45% | 6,101,978 | 149,637 | 487,873 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 04/15/2024 | 04/24/2024 | 0.30% | 6,101,978 | 18,555 | 431,855 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 03/28/2024 | 04/09/2024 | 0.69% | 5,802,275 | 39,956 | 159,852 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 03/15/2024 | 03/26/2024 | 16.63% | 1,050,594 | 174,746 | 372,975 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 02/29/2024 | 03/11/2024 | 9.71% | 1,050,594 | 101,999 | 386,632 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 02/15/2024 | 02/27/2024 | 21.03% | 1,050,594 | 220,911 | 928,318 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 01/31/2024 | 02/09/2024 | 71.89% | 1,050,594 | 755,303 | 1,682,463 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 01/12/2024 | 01/24/2024 | 37.51% | 1,050,594 | 394,050 | 3,285,323 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 12/29/2023 | 01/10/2024 | 1.63% | 24,866,480 | 404,996 | 1,159,267 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 12/15/2023 | 12/27/2023 | 1.76% | 24,866,480 | 437,534 | 2,135,505 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 11/30/2023 | 12/11/2023 | 2.56% | 24,884,323 | 637,234 | 4,389,636 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 11/15/2023 | 11/27/2023 | 2.43% | 19,884,323 | 483,318 | 1,832,496 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 10/31/2023 | 11/09/2023 | 6.64% | 19,884,323 | 1,321,234 | 16,002,850 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 10/13/2023 | 10/24/2023 | 1.70% | 11,734,774 | 199,359 | 1,980,017 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 09/29/2023 | 10/10/2023 | 0.62% | 11,734,774 | 72,766 | 15,974,194 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 09/15/2023 | 09/26/2023 | 4.70% | 2,687,401 | 126,378 | 756,285 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 08/31/2023 | 09/12/2023 | 1.34% | 1,812,401 | 24,365 | 22,152 | 1.1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 08/15/2023 | 08/24/2023 | 0.10% | 1,812,401 | 1,794 | 47,587 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 07/31/2023 | 08/09/2023 | 0.92% | 1,587,894 | 14,685 | 53,355 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 07/14/2023 | 07/25/2023 | 6.39% | 1,587,894 | 101,450 | 177,447 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 06/30/2023 | 07/12/2023 | 3.51% | 1,587,894 | 55,801 | 496,959 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 06/15/2023 | 06/27/2023 | 3.07% | 1,587,894 | 48,737 | 833,907 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 05/31/2023 | 06/09/2023 | 1.09% | 2,488,505 | 27,122 | 46,932 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 05/15/2023 | 05/24/2023 | 69.63% | 636,653 | 443,318 | 198,980 | 2.23 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 04/28/2023 | 05/09/2023 | — | 577,904 | 653,157 | 976,799 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 04/14/2023 | 04/25/2023 | — | 577,904 | 635,995 | 2,365,284 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 03/31/2023 | 04/12/2023 | 55.17% | 577,904 | 318,836 | 140,778 | 2.26 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 03/15/2023 | 03/24/2023 | 45.34% | 581,004 | 263,451 | 330,374 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 02/28/2023 | 03/09/2023 | 93.17% | 581,004 | 541,348 | 2,285,035 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 02/15/2023 | 02/27/2023 | — | 581,004 | 948,440 | 5,288,797 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 01/31/2023 | 02/09/2023 | — | 438,689 | 463,645 | 1,122,285 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 01/13/2023 | 01/25/2023 | — | 438,689 | 459,914 | 308,068 | 1.49 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 12/30/2022 | 01/11/2023 | — | 438,689 | 814,086 | 1,831,764 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 12/15/2022 | 12/27/2022 | — | 438,689 | 1,052,473 | 13,420,667 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 11/30/2022 | 12/09/2022 | 8.11% | 438,689 | 35,579 | 102,575 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 11/15/2022 | 11/25/2022 | 1.72% | 438,689 | 7,565 | 205,217 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 10/31/2022 | 11/09/2022 | 49.88% | 438,689 | 218,814 | 3,560,931 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 10/14/2022 | 10/25/2022 | 8.61% | 438,689 | 37,761 | 20,593 | 1.83 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 09/30/2022 | 10/11/2022 | 8.80% | 438,689 | 38,602 | 21,906 | 1.76 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 09/15/2022 | 09/26/2022 | 1.33% | 438,689 | 5,841 | 20,070 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 08/31/2022 | 09/12/2022 | 1.87% | 438,689 | 8,193 | 21,779 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 08/15/2022 | 08/24/2022 | 0.97% | 438,689 | 4,254 | 22,614 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 07/29/2022 | 08/09/2022 | 2.91% | 438,689 | 12,747 | 18,601 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 07/15/2022 | 07/26/2022 | 2.87% | 438,689 | 12,599 | 11,925 | 1.06 | Get Alert |
Looking for the most shorted stocks?